Target Name: MED13L
NCBI ID: G23389
Review Report on MED13L Target / Biomarker Content of Review Report on MED13L Target / Biomarker
MED13L
Other Name(s): Thyroid hormone receptor-associated protein 2 | PROSIT240 | thyroid hormone receptor-associated protein 2 | DKFZp781D0112 | MD13L_HUMAN | mediator complex subunit 13 like | mediator complex subunit 13L | MRFACD | thyroid hormone receptor-associated protein complex 240 kDa component-like | Mediator complex subunit 13-like | Mediator complex subunit 13L | THRAP2 | FLJ21627 | TRAP240L | Mediator of RNA polymerase II transcription subunit 13-like | KIAA1025 | Thyroid hormone receptor-associated protein complex 240 kDa component-like

MED13L: A Critical Protein for The Regulation of Metabolism

Thyroid hormones are essential for the growth, development, and metabolism of the body. They play a critical role in the regulation of metabolism, which is one of the most critical processes that occur in the body. When thyroid hormones function correctly, they help the body to use energy efficiently, produce proteins and other molecules, and maintain healthy growth and development. However, when thyroid hormones are not produced or are not functioning correctly, it can lead to a range of health problems, including hyperthyroidism and hypothyroidism.

One of the proteins that is associated with the thyroid hormone receptor is called MED13L. MED13L is a protein that is found in the thyroid gland and has been shown to play a critical role in the regulation of metabolism. It is made by the thyroid gland and is important for the function of the thyroid gland.

MED13L is a protein that is composed of four domains: an N-terminus, a C-terminus, a middle domain, and an optional C-terminal tail. The N-terminus of MED13L is located at the protein's unique N-terminus and is responsible for the protein's ability to bind to the thyroid hormone receptor. The C-terminus of MED13L is located at the protein's unique C-terminus and is responsible for the protein's ability to interact with other proteins. The middle domain of MED13L is located between the N-terminus and the C-terminus and is responsible for the protein's unique structure and function.

One of the key functions of MED13L is its ability to interact with the thyroid hormone receptor. The thyroid hormone receptor is a protein that is found in most cells in the body and is responsible for regulating the body's metabolism. The thyroid hormone receptor is composed of two chains: an alpha chain and a beta chain. The alpha chain is located at the protein's N-terminus and is responsible for the receptor's ability to bind to thyroid hormones, while the beta chain is located at the protein's C-terminus and is responsible for the receptor's ability to interact with other proteins.

MED13L has been shown to play a critical role in the regulation of the thyroid hormone receptor. Studies have shown that MED13L is able to interact with the alpha chain of the thyroid hormone receptor and that this interaction is necessary for the receptor's function. Additionally, studies have shown that MED13L is able to modulate the activity of the thyroid hormone receptor in a variety of ways, including by increasing the receptor's activity and by decreasing its activity.

In addition to its role in the regulation of the thyroid hormone receptor, MED13L is also known for its ability to interact with other proteins. Studies have shown that MED13L is able to interact with a variety of proteins, including the transcription factor nuclear factor E2F1 and the protein casein. These interactions are important for the regulation of metabolism and are necessary for the growth, development, and metabolism of the body.

MED13L is also known for its role in the regulation of metabolism in the body. Studies have shown that MED13L is able to regulate the activity of the metabolic enzymes that are responsible for the breakdown of food into energy. This is important for the regulation of metabolism and is necessary for the growth, development, and metabolism of the body.

In conclusion, MED13L is a protein that is associated with the thyroid hormone receptor. It is made by the thyroid gland and plays a critical role in the regulation of metabolism. MED13L is able to interact with the receptor and is necessary for the function of the thyroid gland. Additionally, MED13L is also known for its ability to interact with other proteins and is important for the regulation of metabolism in the body. As a drug target or biomarker, MED13L has the potential to be a valuable tool for the treatment of thyroid hormone-related diseases.

Protein Name: Mediator Complex Subunit 13L

Functions: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway

The "MED13L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MED13L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C | MEF2C-AS1 | MEF2C-AS2 | MEF2D | MEFV | MEG3 | MEG8 | MEG9 | MEGF10 | MEGF11 | MEGF6 | MEGF8 | MEGF9 | MEI1 | MEI4 | MEIG1 | MEIKIN | MEIOB | MEIOC | MEIOSIN | MEIS1 | MEIS1-AS2 | MEIS1-AS3 | MEIS2 | MEIS3 | MEIS3P1 | MEIS3P2 | Melanin | Melanin-concentrating hormone (MCH) receptor | Melanocortin receptor | Melanoma-Associated Antigen | Melatonin receptor | MELK | MELTF | MELTF-AS1 | Membrane-Bound Protein Tyrosine Phosphatases (rPTPs) | Membrane-spanning 4-domains subfamily A member 4A | MEMO1 | MEMO1P1 | MEMO1P4 | MEMO1P5 | MEN1 | MEOX1 | MEOX2 | MEP1A | MEP1AP2 | MEP1AP4 | MEP1B | MEPCE | MEPE | MERTK | MESD | MESP1 | MESP2 | MEST | MESTIT1 | MESTP3 | MESTP4 | MET | Metabotropic glutamate (mGluR) receptor | Metallothionein | METAP1 | METAP1D | METAP2 | Metaxin complex | Methionine adenosyltransferase | Methionine adenosyltransferase II | Methionyl aminopeptidase | Methylcytosine dioxygenase (TET)